Atsushi Takeda, MD, PhD
Affiliations: | Medical Biochemistry | Tohoku University, Sendai-shi, Miyagi-ken, Japan |
Area:
http://www.biomedexperts.com/Profile.bme/1388341/Atsushi_TakedaWebsite:
http://www.labome.org/expert/japan/university/takeda/atsushi-takeda-195538.htmlGoogle:
"Atsushi Takeda"Mean distance: 18.77 (cluster 28) | S | N | B | C | P |
Cross-listing: Alzheimer's Tree - Chemistry Tree
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kawahata I, Takeda A, Fukunaga K. (2024) [Development of early prediction and discriminating techniques for Lewy body diseases]. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica. 159: 2-5 |
| Kawahata I, Sekimori T, Oizumi H, et al. (2023) Using Fatty Acid-Binding Proteins as Potential Biomarkers to Discriminate between Parkinson's Disease and Dementia with Lewy Bodies: Exploration of a Novel Technique. International Journal of Molecular Sciences. 24 |
| Oizumi H, Sugimura Y, Totsune T, et al. (2022) Plasma sphingolipid abnormalities in neurodegenerative diseases. Plos One. 17: e0279315 |
| Kanno S, Shinohara M, Kanno K, et al. (2020) Neural substrates underlying progressive micrographia in Parkinson's disease. Brain and Behavior. e01669 |
| Gang M, Baba T, Hosokai Y, et al. (2020) Clinical and Cerebral Metabolic Changes in Parkinson's Disease With Basal Forebrain Atrophy. Movement Disorders : Official Journal of the Movement Disorder Society |
| Baba T, Takeda A. (2020) Cognitive impairment and its association with cholinergic dysfunction in Parkinson’s disease Neurology and Clinical Neuroscience |
| Kobayashi J, Hasegawa T, Sugeno N, et al. (2019) Extracellular α-synuclein enters dopaminergic cells by modulating flotillin-1-assisted dopamine transporter endocytosis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201802051R |
| Ezura M, Kikuchi A, Ishiki A, et al. (2019) Longitudinal changes in F-THK5351 PET in corticobasal syndrome. European Journal of Neurology |
| Nomoto M, Nagai M, Nishikawa N, et al. (2018) Pharmacokinetics and safety/efficacy of levodopa pro-drug ONO-2160/carbidopa for Parkinson's disease. Eneurologicalsci. 13: 8-13 |
| Hattori N, Takeda A, Takeda S, et al. (2018) Rasagiline monotherapy in early Parkinson's disease: A phase 3, randomized study in Japan. Parkinsonism & Related Disorders |